Estradiol-17β stimulates proliferation of mouse embryonic stem cells: Involvement of MAPKs and CDKs as well as protooncogenes

American Journal of Physiology - Cell Physiology

Volumn 290, Issue 4, 2006, Pages

  Han, Ho Jae ^a   Jung, Sun Heo ^a   Yun, Jung Lee ^a  

^a Chonnam National University   (South Korea)

Author keywords

Cyclin dependent kinase; Mitogen activated protein kinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BROMODEOXYCYTIDINE; BROXURIDINE; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN C JUN; TAMOXIFEN; THYMIDINE; ANTIESTROGEN; DRUG DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; EMBRYONIC STEM CELL; ENZYME PHOSPHORYLATION; IN VITRO STUDY; MOUSE; NONHUMAN; ONCOGENE C FOS; ONCOGENE C MYC; PRIORITY JOURNAL; PROTO ONCOGENE; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; PHYSIOLOGY; STEM CELL;

ANIMALIA; MURINAE;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASES; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENES; SIGNAL TRANSDUCTION; STEM CELLS; TAMOXIFEN; THYMIDINE;

EID: 33646435306     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00222.2005     Document Type: Article

References (54)

1. Altundag K, Altundag O, Gunduz M, and Arun B. Possible interaction between activator protein-1 and proto-oncogene B-cell lymphoma gene 6 in breast cancer patients resistant to tamoxifen. Med Hypotheses 63: 823-826, 2004.
2. Amit M, Carpenter MK, Inokuma MS, Chiu CP, Harris CP, Waknitz MA, Itskovitz-Eldor J, and Thomson JA. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 15: 271-278, 2000.
3. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
4. Brännvall K, Korhonen L, and Lindholm D. Estrogen-receptor-dependent regulation of neural stem cell proliferation and differentiation. Mol Cell Neurosci 21: 512-520, 2002.
5. Brett CM, Washington CB, Ott RJ, Gutierrez MM, and Giacomini KM. Interaction of nucleoside analogues with the sodium-nucleoside transport system in brush border membrane vesicles from human kidney. Pharm Res 10: 423-426, 1993.
6. Chambliss KL, Yuhanna IS, Mineo C, Liu P, German Z, Sherman TS, Mendelsohn ME, Anderson RG, and Shaul PW. Estrogen receptor α and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ Res 87: E44-E52, 2000.
7. Clarke R, Leonessa F, Welch JN, and Skaar TC. Cellular and molecular pharmacology of antiestrogen action and resistance. Pharmacol Rev 53: 25-71, 2001.
8. Cogle CR, Guthrie SM, Sanders RC, Allen WL, Scott EW, and Petersen BE. An overview of stem cell research and regulatory issues. Mayo Clin Proc 78: 993-1003, 2003.
9. Couse JF and Korach K. Estrogen-receptor null mice: what have we learned and where will they lead us? Endocr Rev 20: 358-417, 1999.
10. Das SK, Tan J, Raja S, Halder J, Paria BC, and Dey SK. Estrogen targets genes involved in protein processing, calcium homeostasis, and Wnt signaling in the mouse uterus independent of estrogen receptor-α and -β. J Biol Chem 275: 28834-28842, 2000.
11. Doisneau-Sixou SF, Sergio CM, Carroll JS, Hui R, Musgrove EA, and Sutherland RL. Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells. Endocr Relat Cancer 10: 179-186, 2003.
12. Dubey RK, Gillespie DG, Jackson EK, and Keller PJ. 17β-Estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth. Hypertension 31: 522-528, 1998.
13. Dubik D and Shiu RP. Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7: 1587-1594, 1992.
14. Edwards DP. Regulation of signal transcription pathways by estrogen and progesterone. Annu Rev Physiol 67: 335-376, 2005.
15. Evans MJ and Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 292: 154-156, 1981.
16. Gaben AM, Saucier C, Bedin M, Redeuilh G, and Mester J. Mitogenic activity of estrogens in human breast cancer cells does not rely on direct induction of mitogen-activated protein kinase/extracellularly regulated kinase or phosphatidylinositol 3-kinase. Mol Endocrinol 18: 2700-2713, 2004.
17. 1-phase. J Biol Chem 279: 13640-13644, 2004.
18. Grohé C, Kahlert S, Löbbert K, van Eickels M, Stimpel M, Vetter H, and Neyses L. Effects of moexiprilat on oestrogen-stimulated cardiac fibroblast growth. Br J Pharmacol 121: 1350-1354, 1997.
19. Hou Q and Gorski J. Estrogen-receptor and progesterone-receptor genes are expressed differently in mouse embryos during periimplantation development. Proc Natl Acad Sci USA 90: 9460-9464, 1993.
20. Hou A, Paria BC, Mui C, Dey SK, and Gorski J. Immunolocalization of estrogen receptor protein in the mouse blastocyst during normal and delayed implantation. Proc Natl Acad Sci USA 93: 2376-2381, 1996.
21. Järvinen TAH, Pelto-Huikko M, Holli K, and Isola J. Estrogen receptor β is coexpressed with ERα and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Am J Pathol 156: 29-35, 2000.
22. Kahlert S, Nuedling S, van Eickels M, Vetter H, Meyer R, and Grohé C. Estrogen receptor a rapidly activates the IGF-1 receptor pathway. J Biol Chem 275: 18447-18453, 2000.
23. Kato S, Kitamoto T, Masuhiro Y, and Yanagisawa J. Molecular mechanism of a cross-talk between estrogen and growth-factor signaling pathways. Oncology 55, Suppl 1: 5-10, 1998.
24. Katzenellenbogen BS. Estrogen receptors: bioactivities and interactions with cell signaling pathways. Biol Reprod 54: 287-293, 1996.
25. Katzenellenbogen BS, Montano MM, Ekna K, Herman ME, and McInerney EM. William L. McGuire Memorial Lecture. Antiestrogens: mechanisms of action and resistance in breast cancer. Breast Cancer Res Treat 44: 23-38, 1997.
26. Kelly MJ and Levin ER. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab 12: 152-156, 2001.
27. Krupnick JG, Damjanov I, Damjanov A, Zhu ZM, and Fenderson BA. Globo-series carbohydrate antigens are expressed in different forms on human and murine teratocarcinoma-derived cells. Int J Cancer 59: 692-698, 1994.
28. Lee HW and Eghbali-Webb M. Estrogen enhances proliferative capacity of cardiac fibroblasts by estrogen receptor- and mitogen activated protein kinase-dependent pathway. Br J Pharmacol 121: 1350-1354, 1998.
29. Lobenhofer EK, Huper G, Iglehart JD, and Marks JR. Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis. Cell Growth Differ 11: 99-110, 2000.
30. Maggiolini M, Vivacqua A, Fasanella G, Recchia AG, Sisci D, Pezzi V, Montanaro D, Musti AM, Picard D, and Andò S. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17β-estradiol and phytoestrogens in breast cancer cells. J Biol Chem 279: 27008-27016, 2004.
31. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, and Evans RM. The nuclear receptor superfamily: the second decade. Cell 83: 835-839, 1995.
32. Manole D, Schildknecht B, Gosnell B, Adams E, and Derwahl M. Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab 86: 1072-1077, 2001.
33. Matsui Y, Zsebo K, and Hogan BL. Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell 70: 841-847, 1992.
34. 3 and fibronectin mRNAs but exhibit a disparate action on cardiac fibroblast proliferation. Cardiovasc Res 53: 728-739, 2002.
35. Molenda HA, Kilts CP, Allen RL, and Tetel MJ. Nuclear receptor coactivator function in reproductive physiology and behavior. Biol Reprod 69: 1449-1457, 2003.
36. Nethrapalli IS, Tinnikov AA, Krishnan V, Lei CD, and Toran-Allerand CD. Estrogen activates mitogen-activated protein kinase in native, nontransfected CHO-K1, COS-7, and RAT2 fibroblast cell lines. Endocrinology 146: 56-63, 2005.
37. Pedram A, Razandi M, Aitkenhead M, Hughes CC, and Levin ER. Integration of the non-genomic and genomic actions of estrogen: membrane-initiated signaling by steroid to transcription and cell biology. J Biol Chem 277: 50768-50775, 2002.
38. Pesce M and Schöler HR. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 19: 271-278, 2001.
39. 1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J Biol Chem 272: 10882-10894, 1997.
40. Razandi M, Oh P, Pedram A, Schnitzer J, and Levin ER. ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol Endocrinol 16: 100-115, 2002.
41. Rosner MH, Vigano MA, Ozato K, Timmons PM, Poirier F, Rigby PWJ, and Staudt LM. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345: 686-692, 1990.
42. Sak K and Everaus H. Nongenomic effects of 17β-estradiol: diversity of membrane binding sites. J Steroid Biochem Mol Biol 88: 323-335, 2004.
43. 1-phase progression. Genes Dev 13: 1501-1512, 1999.
44. Simoncini T and Genazzani AR. Non-genomic actions of sex steroid hormones. Eur J Endocrinol 148: 281-292, 2003.
45. Simoncini T, Mannella P, Fornari L, Caruso A, Varone G, and Genazzani AR. Genomic and non-genomic effects of estrogens on endothelial cells. Steroids 69: 537-542, 2004.
46. Smith AG. Mouse embryo stem cells: their identification, propagation and manipulation. Semin Cell Biol 3: 385-399, 1992.
47. Sung JH, Yoon HS, Lee JS, Kim CG, Kim MK, and Yoon YD. Differentiation and apoptosis of the mammalian embryo and embryonic stem cells (ESC). I. Establishment of mouse ESC and induction of differentiation by reproductive hormones. Dev Reprod 6: 55-66, 2002.
48. Sutherland RL and Musgrove EA. Cyclins and breast cancer. J Mammary Gland Biol Neoplasia 9: 95-104, 2004.
49. Tasi MJ and O'Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63: 451-486, 1994.
50. Thomas P, Pang Y, Filardo EJ, and Dong J. Identity of an estrogen membrane receptor coupled to a G-protein in human breast cancer cells. Endocrinology 146: 624-632, 2005.
51. Vermeulen K, Van Bockstaele DR, and Berneman ZN. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 36: 131-149, 2003.
52. Watters JJ, Campbell JS, Cunningham MJ, Krebs EG, and Dorsa DM. Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology 138: 4030-4033, 1997.
53. Weigel NL. Steroid hormone receptors and their regulation by phosphorylation. Biochem J 319: 657-667, 1996.
54. αi. J Biol Chem 276: 27071-27076, 2001.